Viveve Geneveve Treatment of the Vaginal Introitus to Evaluate Safety and Efficacy

Inclusion Criteria: * 18 years of age at time of screening and pre-menopausal * At least one vaginal delivery (\> 37 completed weeks gestation) * Sexual dysfunction * Negative pregnancy test at Screening visit * Sexually active Exclusion Criteria: * Currently breastfeeding or recently discontinued breastfeeding * Medical history of keloid formation, genital fistula, thin recto-vaginal septum or obstetric trauma * Implantable electrical device * Medical or immunological condition * Chronic use of anti-inflammatory drugs * Current or previous use of local vaginal hormones * Undergone previous elective surgical or non-invasive procedure(s) at the vaginal introitus